Working… Menu
Trial record 3 of 896 for:    LENALIDOMIDE

Lenalidomide in Anti-MAG Neuropathy: Phase 1b Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03701711
Recruitment Status : Recruiting
First Posted : October 10, 2018
Last Update Posted : July 24, 2019
Information provided by (Responsible Party):
Bakri Elsheikh, Ohio State University

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 30, 2020
Estimated Study Completion Date : September 30, 2020